LRP5 polymorphisms and response to risedronate treatment in osteoporotic men

Calcified Tissue International

Volumn 84, Issue 3, 2009, Pages 171-179

  Kruk, Marcin ^a   Ralston, Stuart H ^a   Albagha, Omar M E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bone; Bone density; LRP5; Osteoporosis; Polymorphism

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; DNA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; PLACEBO; RISEDRONIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DOUBLE-BLIND METHOD; ETIDRONIC ACID; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 62349136652     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-008-9207-5     Document Type: Article

References (39)

1. B Gullberg O Johnell JA Kanis 1997 World-wide projections for hip fracture Osteoporos Int 7 407 413
2. LE Wehren WG Hawkes DL Orwig JR Hebel SI Zimmerman J Magaziner 2003 Gender differences in mortality after hip fracture: the role of infection J Bone Miner Res 18 2231 2237
3. E Seeman G Bianchi S Khosla JA Kanis E Orwoll 2006 Bone fragility in men-where are we? Osteoporos Int 17 1577 1583
4. NA Pocock JA Eisman JL Hopper MG Yeates PN Sambrook S Eberl 1987 Genetic determinants of bone mass in adults. A twin study J Clin Invest 80 706 710
5. TV Nguyen J Blangero JA Eisman 2000 Genetic epidemiological approaches to the search for osteoporosis genes J Bone Miner Res 15 392 401
6. Y Gong M Vikkula L Boon J Liu P Beighton R Ramesar L Peltonen H Somer T Hirose B Dallapiccola A De Paepe W Swoboda B Zabel A Superti-Furga B Steinmann HG Brunner A Jans RG Boles W Adkins MJ van den Boogaard BR Olsen ML Warman 1996 Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13 Am J Hum Genet 59 146 151
7. Y Gong RB Slee N Fukai G Rawadi S Roman-Roman AM Reginato H Wang T Cundy FH Glorieux D Lev M Zacharin K Oexle J Marcelino W Suwairi S Heeger G Sabatakos S Apte WN Adkins J Allgrove M Arslan-Kirchner JA Batch P Beighton GC Black RG Boles LM Boon C Borrone HG Brunner GF Carle B Dallapiccola A De Paepe B Floege ML Halfhide B Hall RC Hennekam T Hirose A Jans H Juppner CA Kim K Keppler-Noreuil A Kohlschuetter D LaCombe M Lambert E Lemyre T Letteboer L Peltonen RS Ramesar M Romanengo H Somer E Steichen-Gersdorf B Steinmann B Sullivan A Superti-Furga W Swoboda MJ van den Boogaard W Van Hul M Vikkula M Votruba B Zabel T Garcia R Baron BR Olsen ML Warman 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development Cell 107 513 523
8. M Kato MS Patel R Levasseur I Lobov BH Chang DA Glass C Hartmann L Li TH Hwang CF Brayton RA Lang G Karsenty L Chan 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor J Cell Biol 157 303 314
9. RD Little JP Carulli RG Del Mastro J Dupuis M Osborne C Folz SP Manning PM Swain SC Zhao B Eustace MM Lappe L Spitzer S Zweier K Braunschweiger Y Benchekroun X Hu R Adair L Chee MG FitzGerald C Tulig A Caruso N Tzellas A Bawa B Franklin S McGuire X Nogues G Gong KM Allen A Anisowicz AJ Morales PT Lomedico SM Recker P Van Eerdewegh RR Recker ML Johnson 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait Am J Hum Genet 70 11 19
10. LM Boyden J Mao J Belsky L Mitzner A Farhi MA Mitnick D Wu K Insogna RP Lifton 2002 High bone density due to a mutation in LDL-receptor-related protein 5 N Engl J Med 346 1513 1521
11. M Ai SL Holmen W Van Hul BO Williams ML Warman 2005 Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling Mol Cell Biol 25 4946 4955
12. W Balemans JP Devogelaer E Cleiren E Piters E Caussin W Van Hul 2007 Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling J Bone Miner Res 22 708 716
13. SL Ferrari S Deutsch U Choudhury T Chevalley JP Bonjour ET Dermitzakis R Rizzoli SE Antonarakis 2004 Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites Am J Hum Genet 74 866 875
14. T Mizuguchi I Furuta Y Watanabe K Tsukamoto H Tomita M Tsujihata T Ohta T Kishino N Matsumoto H Minakami N Niikawa K Yoshiura 2004 LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density J Hum Genet 49 80 86
15. SL Ferrari S Deutsch C Baudoin M Cohen-Solal A Ostertag SE Antonarakis R Rizzoli MC de Vernejoul 2005 LRP5 gene polymorphisms and idiopathic osteoporosis in men Bone 37 770 775
16. DL Koller S Ichikawa ML Johnson D Lai X Xuei HJ Edenberg PM Conneally SL Hui CC Johnston M Peacock T Foroud MJ Econs 2005 Contribution of the LRP5 gene to normal variation in peak BMD in women J Bone Miner Res 20 75 80
17. JB van Meurs F Rivadeneira M Jhamai W Hugens A Hofman JP van Leeuwen HA Pols AG Uitterlinden 2006 Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men J Bone Miner Res 21 141 150
18. A Saarinen VV Valimaki MJ Valimaki E Loyttyniemi K Auro P Uusen M Kuris AE Lehesjoki O Makitie 2007 The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men Bone 40 1006 1012
19. K Brixen S Beckers A Peeters E Piters W Balemans TL Nielsen K Wraae L Bathum C Brasen C Hagen M Andersen W Van Hul B Abrahamsen 2007 Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense Androgen Study Calcif Tissue Int 81 421 429
20. DP Kiel SL Ferrari LA Cupples D Karasik D Manen A Imamovic AG Herbert J Dupuis 2007 Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men Bone 40 587 596
21. Y Ezura T Nakajima T Urano Y Sudo M Kajita H Yoshida T Suzuki T Hosoi S Inoue M Shiraki M Emi 2007 Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women Bone 40 997 1005
22. J Bollerslev SG Wilson IM Dick FM Islam T Ueland L Palmer A Devine RL Prince 2005 LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women Bone 36 599 606
23. JB van Meurs TA Trikalinos SH Ralston S Balcells ML Brandi K Brixen DP Kiel BL Langdahl P Lips O Ljunggren R Lorenc B Obermayer-Pietsch C Ohlsson U Pettersson DM Reid F Rousseau S Scollen W Van Hul L Agueda K Akesson LI Benevolenskaya SL Ferrari G Hallmans A Hofman LB Husted M Kruk S Kaptoge D Karasik MK Karlsson M Lorentzon L Masi FE McGuigan D Mellstrom L Mosekilde X Nogues HA Pols J Reeve W Renner F Rivadeneira NM van Schoor K Weber JP Ioannidis AG Uitterlinden 2008 Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis JAMA 299 1277 1290
24. S Giroux L Elfassihi G Cardinal N Laflamme F Rousseau 2007 LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women Bone 40 1299 1307
25. W Balemans W Van Hul 2007 The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes Endocrinology 148 2622 2629
26. AM Qureshi RJ Herd GM Blake I Fogelman SH Ralston 2002 COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy Calcif Tissue Int 70 158 163
27. J Marc J Prezelj R Komel A Kocijancic 1999 VDR genotype and response to etidronate therapy in late postmenopausal women Osteoporos Int 10 303 306
28. S Palomba FG Numis G Mossetti D Rendina P Vuotto T Russo F Zullo C Nappi V Nunziata 2003 Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes Clin Endocrinol (Oxf) 58 365 371
29. S Palomba F Orio Jr T Russo A Falbo A Tolino F Manguso V Nunziata P Mastrantonio G Lombardi F Zullo 2005 BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial Osteoporos Int 16 943 952
30. W Yao ZQ Cheng C Busse A Pham MC Nakamura NE Lane 2008 Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis-a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice Arthritis Rheum 58 1674 1686
31. W Yao A Pham Z Cheng C Busse NE Lane 2006 Glucocorticoid suppression of the canonical Wnt signaling is partially reversed by PTH and risedronate in mice J Bone Miner Res 21 S122
32. T Becker M Knapp 2004 Maximum-likelihood estimation of haplotype frequencies in nuclear families Genet Epidemiol 27 21 32
33. MA Koay JH Tobias SD Leary CD Steer C Vilarino-Guell MA Brown 2007 The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood Calcif Tissue Int 81 1 9
34. JB Richards F Rivadeneira M Inouye TM Pastinen N Soranzo SG Wilson T Andrew M Falchi R Gwilliam KR Ahmadi AM Valdes P Arp P Whittaker DJ Verlaan M Jhamai V Kumanduri M Moorhouse JB van Meurs A Hofman HA Pols D Hart G Zhai BS Kato BH Mullin F Zhang P Deloukas AG Uitterlinden TD Spector 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study Lancet 371 1505 1512
35. S Palomba FG Numis G Mossetti D Rendina P Vuotto T Russo F Zullo C Nappi V Nunziata 2003 Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes Hum Reprod 18 192 198
36. P Babij W Zhao C Small Y Kharode PJ Yaworsky ML Bouxsein PS Reddy PV Bodine JA Robinson B Bhat J Marzolf RA Moran F Bex 2003 High bone mass in mice expressing a mutant LRP5 gene J Bone Miner Res 18 960 974
37. MP Akhter DJ Wells SJ Short DM Cullen ML Johnson GR Haynatzki P Babij KM Allen PJ Yaworsky F Bex RR Recker 2004 Bone biomechanical properties in LRP5 mutant mice Bone 35 162 169
38. FE McGuigan L Murray A Gallagher G Davey-Smith CE Neville R Van't Hof C Boreham SH Ralston 2002 Genetic and environmental determinants of peak bone mass in young men and women J Bone Miner Res 17 1273 1279
39. SS Dhamrait L James DJ Brull S Myerson E Hawe DJ Pennell M World SE Humphries F Haddad HE Montgomery 2003 Cortical bone resorption during exercise is interleukin-6 genotype-dependent Eur J Appl Physiol 89 21 25